Viveon Health Acquisition Corp (VHAQ) Return on Investment ROI from the first quarter of 2023 to first quarter of 2022 and for the year 2023, average high and low, overall ranking from Mar 31 2023 to Mar 31 2022 - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Viveon Health Acquisition Corp   (NYSE: VHAQ)


Viveon Health Acquisition's ROI from its first quarter of 2023 to the first quarter of 2022 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Viveon Health Acquisition's ROI in the first quarter of 2023?
Viveon Health Acquisition Corp achieved a return on average invested assets (ROI) of 7.8 % in its first quarter of 2023 a new company high.

Despite the deterioration in its net income, company has improved ROI compared to the fourth quarter of 2022.

Within the Healthcare sector 112 other companies had a higher return on investment. While Return on investment, overall ranking has progressed in the Mar 31 2023 quarter, so far to 1052, from total ROI ranking in the fourth quarter of 2022 at 3687.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Mar 31 2023)
I. Quarter		 (Dec 31 2022)
IV. Quarter		 (Sep 30 2022)
III. Quarter		 (Jun 30 2022)
II. Quarter		 (Mar 31 2022)
I. Quarter
Y / Y Investment Change TTM -62.1 % -88.63 % -94 % - -8.31 %
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions 13 13 43 -8 -8
Return On Investment (TTM) 7.8 % -6.1 % -101.33 % - -
VHAQ's Overall Ranking # 1052 # 3687 # 4304 # 0 # 0
Seq. Investment Change TTM 52.56 % 90.09 % - - -54.23 %
Seq. Net Income Change TTM - - - - -
Net Income (TTM) in Millions 1 -1 -5 -2 -4

VHAQ Company Profile >> Back to VHAQ Roi Comparisons >> See Annual VHAQ Return On Investment



Return On Investment VHAQ's Ranking
Within: No.
Industry # 53
Sector # 113
Overall # 1052

Return On Investment Statistics
High Average Low
7.8 %
-19.77 %
-77.53 %
(Mar 31 2023)   (Sep 30 2022)







Financial Statements
Viveon Health Acquisition's I. Quarter Investments $ 13 Millions VHAQ's Balance sheet
Viveon Health Acquisition's I. Quarter Income $ 0 Millions Quarterly VHAQ's Income Statement
VHAQ's Income by Division See VHAQ's Income by Division


VHAQ Annual Return On Investment (Dec 31 2022)
2022		 (Dec 31 2021)
2021		 (Dec 31 2020)
2020

Total Investments in Millions 13 -6 195 0 0
Y / Y Investment Growth - - - - -
Net Income in Millions -1 2 -2 0 0
Y / Y Net Income Growth - - - - -
Annual Return On Investment -4.69 % - -1.15 % - -


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Major Pharmaceutical Preparations Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
VHAQ's Roi Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for VHAQ's Competitors
Subscribers only: Roi for Viveon Health Acquisition's Suppliers
Subscribers only: Return On Investment for VHAQ's Customers

Other Ratios
VHAQ's Roa VHAQ's Inventory Turnover Ratio VHAQ's Growth Rates VHAQ's Dividend Statistics
VHAQ's Profitability Ratios VHAQ's Asset Turnover Ratio VHAQ's Dividend Growth
VHAQ's Roe VHAQ's Valuation Ratios VHAQ's Financial Strength Ratios VHAQ's Dividend Payout Ratio



Companies with similar Return On Investment at Mar 31 2023, within Healthcare Sector ROI
Siga Technologies Inc  20.24 %
Innoviva Inc   20.18 %
Pro dex Inc   19.98 %
Chemed Corporation  19.95 %
Edwards Lifesciences Corporation  19.78 %
Corcept Therapeutics Inc  19.07 %
Dr Reddy s Laboratories Limited  19.07 %
Iradimed Corporation  19.01 %
Waters Corporation  18.98 %
Pfizer Inc  18.88 %
West Pharmaceutical Services Inc   18.49 %
Zynex inc   18.06 %
Zoetis Inc   17.90 %
Eli Lilly And Company  17.80 %
Ironwood Pharmaceuticals inc   17.58 %
Tenax Therapeutics Inc   17.51 %
Resmed Inc   17.16 %
Regeneron Pharmaceuticals Inc   16.93 %
Merck and Co Inc   16.68 %
Omeros Corporation  16.14 %
Agilent Technologies inc   15.42 %
3m Company  15.00 %
Amgen Inc   14.94 %
Utah Medical Products Inc  14.76 %
Biogen Inc   14.71 %
Amphastar Pharmaceuticals Inc   14.56 %
Carlisle Companies Incorporated  14.08 %
Hca Healthcare Inc   13.97 %
Escalon Medical Corp   13.92 %
Precigen Inc   13.77 %

Date modified: 2026-09-08T15:11:17+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.